DK0408711T3 - S-adenosylmethionin til behandling af pancreatitis og immunafstødning ved pancreastransplantationer - Google Patents

S-adenosylmethionin til behandling af pancreatitis og immunafstødning ved pancreastransplantationer

Info

Publication number
DK0408711T3
DK0408711T3 DK90902247.7T DK90902247T DK0408711T3 DK 0408711 T3 DK0408711 T3 DK 0408711T3 DK 90902247 T DK90902247 T DK 90902247T DK 0408711 T3 DK0408711 T3 DK 0408711T3
Authority
DK
Denmark
Prior art keywords
pancreatitis
treatment
pct
adenosylmethionine
immune rejection
Prior art date
Application number
DK90902247.7T
Other languages
English (en)
Inventor
Ian V Hutchinson
Joan M Braganza
Original Assignee
Bioresearch Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch Spa filed Critical Bioresearch Spa
Application granted granted Critical
Publication of DK0408711T3 publication Critical patent/DK0408711T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
DK90902247.7T 1989-01-14 1990-01-10 S-adenosylmethionin til behandling af pancreatitis og immunafstødning ved pancreastransplantationer DK0408711T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898900812A GB8900812D0 (en) 1989-01-14 1989-01-14 Pharmaceutical method and compositions

Publications (1)

Publication Number Publication Date
DK0408711T3 true DK0408711T3 (da) 1994-06-06

Family

ID=10650037

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90902247.7T DK0408711T3 (da) 1989-01-14 1990-01-10 S-adenosylmethionin til behandling af pancreatitis og immunafstødning ved pancreastransplantationer

Country Status (15)

Country Link
US (1) US5196402A (da)
EP (1) EP0408711B1 (da)
JP (1) JPH03503289A (da)
KR (1) KR910700055A (da)
AT (1) ATE104551T1 (da)
AU (1) AU630159B2 (da)
CA (1) CA2026580A1 (da)
DE (1) DE69008258T2 (da)
DK (1) DK0408711T3 (da)
ES (1) ES2055415T3 (da)
GB (1) GB8900812D0 (da)
HU (1) HU206626B (da)
RU (1) RU2014837C1 (da)
WO (1) WO1990007928A1 (da)
ZA (1) ZA90241B (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1243859B (it) * 1990-10-23 1994-06-28 Bioresearch Spa Composizioni farmaceutiche comprendenti associazioni fra sali di s-adenosil-l-metionina e acido 5-metil (o 5-formil)-tetraidrofolico per la terapia di complicanze neurologiche negli ammalati di aids.
US6492349B1 (en) * 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
US5508262A (en) * 1993-12-15 1996-04-16 University Of South Florida Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
US5747461A (en) * 1994-07-26 1998-05-05 Markov; Angel K. Synergistic administration of cyclosporine and fructose diphosphate
US5723116A (en) * 1995-01-06 1998-03-03 University Of South Florida Decreased mortality of severe acute pancreatitis following proximal cytokine blockade
GB2312621B (en) * 1996-05-02 1998-03-11 Pharma Nord Uk Limited Anti-oxidant medicament
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
US6063600A (en) * 1997-05-23 2000-05-16 Uab Research Foundation DNA encoding canine interleukin-1 receptor antagonist
US6399093B1 (en) 1999-05-19 2002-06-04 Advanced Medical Instruments Method and composition to treat musculoskeletal disorders
WO2004037168A2 (en) * 2002-10-18 2004-05-06 Amylin Pharmaceuticals, Inc. Treatment of pancreatitis with amylin
US20050272687A1 (en) * 2004-06-08 2005-12-08 Hebert Rolland F Stable S-adenosyl-l-methionine
EP1879027B1 (en) * 2005-04-27 2013-06-12 CytoPathfinder, Inc. Agent for preventing and treating pancreatitis
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
US9039962B2 (en) 2010-03-30 2015-05-26 Nippon Steel & Sumitomo Metal Corporation Steel for induction hardening, roughly shaped material for induction hardening, producing method thereof, and induction hardening steel part
JP5877935B2 (ja) * 2012-10-17 2016-03-08 メチレーション・サイエンシーズ・インターナショナル・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティＭｅｔｈｙｌａｔｉｏｎ Ｓｃｉｅｎｃｅｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ Ｓｒｌ Ｓ−アデノシルメチオニンおよび没食子酸エステルを含む組成物
WO2024238657A2 (en) 2023-05-15 2024-11-21 Bonafide Health, Llc Sleep-improving compositions and methods of use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1169772B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche per uso orale contenenti sali stabili della s-adenosil-l-metionina
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
ATE80165T1 (de) * 1987-10-09 1992-09-15 Vincenzo Zappia Lipophile salze von s-adenosyl-l-methionin (sam) mit acyltaurinderivaten.

Also Published As

Publication number Publication date
DE69008258T2 (de) 1994-08-04
AU5026090A (en) 1990-08-13
ATE104551T1 (de) 1994-05-15
GB8900812D0 (en) 1989-03-08
ZA90241B (en) 1991-03-27
AU630159B2 (en) 1992-10-22
JPH03503289A (ja) 1991-07-25
ES2055415T3 (es) 1994-08-16
EP0408711B1 (en) 1994-04-20
HUT54893A (en) 1991-04-29
HU901516D0 (en) 1991-03-28
US5196402A (en) 1993-03-23
HU206626B (en) 1992-12-28
RU2014837C1 (ru) 1994-06-30
EP0408711A1 (en) 1991-01-23
CA2026580A1 (en) 1990-07-15
KR910700055A (ko) 1991-03-13
DE69008258D1 (de) 1994-05-26
WO1990007928A1 (en) 1990-07-26

Similar Documents

Publication Publication Date Title
DK0408711T3 (da) S-adenosylmethionin til behandling af pancreatitis og immunafstødning ved pancreastransplantationer
MX173183B (es) Uso de la rapamicina para la preparacion de una composicion para inhibir el rechazo de transplantes de organos o tejidos en un mamifero que lo necesita
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
DK1066052T3 (da) Mesenchymstamceller til forebyggelse og behandling af immunreaktioner ved transplantationer
PL349028A1 (en) Cancer treatment composition and method using natural plant essential oils
MX9101869A (es) Ciclosporinas, composicion farmaceutica que las contiene y procedimiento para la produccion de las mismas
ES2099158T3 (es) Tratamiento del rechazo de trasplantes o de enfermedades autoinmunitarias y complejo de la formula general x-pro-y-boropro asociada al mismo.
NL300787I1 (da)
DK0675708T3 (da) Farmaceutiske og dermokosmetiske sammensætninger indeholdende heste-colostrum.
ATE185548T1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
DE69435303D1 (de) Er behandlung von krankheiten bei denen eine cytok
BR9306345A (pt) Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune
GR3027668T3 (en) Immunosuppressive compositions
PT97277A (pt) Processo para a preparacao de formulacoes farmaceuticas, contendo, por exemplo, ciclosporina a e factor de veneno de cobracapelo, uteis para a inibicao da rejeicao de aloenxerto e de xenoenxerto concordante
DK0506716T3 (da) Fremgangsmåde til behandling af trombocytopeni og farmaceutiske præparater egnet dertil
GR3034142T3 (en) Composition for the treatment or prevention of herpes
DK630088D0 (da) Azelastinembonat, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater med indhold af denne forbindelse som aktivt middel
ATE174694T1 (de) Armband- oder taschenuhr
MXPA04005097A (es) Composicion y metodo para tratar el rechazo cronico de aloinjertos.
DK0625351T3 (da) Anvendelse af etofibrat og farmaceutiske præparater indeholdende etofibrat til behandling af diabetisk angio- og retinopati
SE8303886D0 (sv) Synergetisk antihypertensiv farmaceutisk komposition
ATE283063T1 (de) Allogene und xenogene transplantation
MX9710304A (es) Composiciones para la preparacion de cuero.